Administration of Vaginal and Rectal Progesterone During FET Cycles

NCT03470610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 277

Last updated 2019-09-10

No results posted yet for this study

Summary

Observational study of reproductive outcome after frozen embryo transfer in HRT with vaginal and rectal progesterone.

Conditions

Interventions

DRUG

Progesterone

6 mg estradiol and vaginal and rectal progesterone

Sponsors & Collaborators

  • Thor Haahr

    lead OTHER

Principal Investigators

  • Peter Humaidan, DMsc · Fertility Clinic Skive

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-02-01
Completion
2019-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470610 on ClinicalTrials.gov